Smart multifunctional polyurethane microcapsules for the quick release of anticancer drugs in BGC 823 and HeLa tumor cells

2017 ◽  
Vol 5 (48) ◽  
pp. 9477-9481 ◽  
Author(s):  
Yuqing Niu ◽  
Florian J. Stadler ◽  
Tao He ◽  
Xingcai Zhang ◽  
Yingjie Yu ◽  
...  

Smart fluorescent polyurethane microcapsules with high tumor cell internalization, triggered release were developed for precision real-time monitoring cancer therapy.

2020 ◽  
Vol 27 (13) ◽  
pp. 2118-2132 ◽  
Author(s):  
Aysegul Hanikoglu ◽  
Hakan Ozben ◽  
Ferhat Hanikoglu ◽  
Tomris Ozben

: Elevated Reactive Oxygen Species (ROS) generated by the conventional cancer therapies and the endogenous production of ROS have been observed in various types of cancers. In contrast to the harmful effects of oxidative stress in different pathologies other than cancer, ROS can speed anti-tumorigenic signaling and cause apoptosis of tumor cells via oxidative stress as demonstrated in several studies. The primary actions of antioxidants in cells are to provide a redox balance between reduction-oxidation reactions. Antioxidants in tumor cells can scavenge excess ROS, causing resistance to ROS induced apoptosis. Various chemotherapeutic drugs, in their clinical use, have evoked drug resistance and serious side effects. Consequently, drugs having single-targets are not able to provide an effective cancer therapy. Recently, developed hybrid anticancer drugs promise great therapeutic advantages due to their capacity to overcome the limitations encountered with conventional chemotherapeutic agents. Hybrid compounds have advantages in comparison to the single cancer drugs which have usually low solubility, adverse side effects, and drug resistance. This review addresses two important treatments strategies in cancer therapy: oxidative stress induced apoptosis and hybrid anticancer drugs.


Head & Neck ◽  
2013 ◽  
Vol 36 (8) ◽  
pp. 1207-1215 ◽  
Author(s):  
Mazen A. Juratli ◽  
Mustafa Sarimollaoglu ◽  
Eric R. Siegel ◽  
Dmitry A. Nedosekin ◽  
Ekaterina I. Galanzha ◽  
...  

Author(s):  
Dong-Hui Wang ◽  
Li-Jian Chen ◽  
Xu Zhao ◽  
Xiu-Ping Yan

Phototheranostics has attracted great interest in cancer therapy. Small-molecule self-reporting photosensitizers, one kind of idea agents in phototheranostics, enable simultaneous photodynamic therapy (PDT) and feedback of therapeutic efficacy. However, previous...


Pharmaceutics ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 1905
Author(s):  
Irina S. R. Rio ◽  
Ana Rita O. Rodrigues ◽  
Juliana M. Rodrigues ◽  
Maria-João R. P. Queiroz ◽  
R. C. Calhelha ◽  
...  

Liposome-like nanoarchitectures containing manganese ferrite nanoparticles covered or decorated with gold were developed for application in dual cancer therapy, combining chemotherapy and photothermia. The magnetic/plasmonic nanoparticles were characterized using XRD, UV/Visible absorption, HR-TEM, and SQUID, exhibiting superparamagnetic behavior at room temperature. The average size of the gold-decorated nanoparticles was 26.7 nm for MnFe2O4 with 5–7 nm gold nanospheres. The average size of the core/shell nanoparticles was 28.8 nm for the magnetic core and around 4 nm for the gold shell. Two new potential antitumor fluorescent drugs, tricyclic lactones derivatives of thienopyridine, were loaded in these nanosystems with very high encapsulation efficiencies (higher than 98%). Assays in human tumor cell lines demonstrate that the nanocarriers do not release the antitumor compounds in the absence of irradiation. Moreover, the nanosystems do not cause any effect on the growth of primary (non-tumor) cells (with or without irradiation). The drug-loaded systems containing the core/shell magnetic/plasmonic nanoparticles efficiently inhibit the growth of tumor cells when irradiated with red light, making them suitable for a triggered release promoted by irradiation.


2007 ◽  
Vol 282 (49) ◽  
pp. 35430-35439 ◽  
Author(s):  
Susumu Tanimura ◽  
A-i Hirano ◽  
Junya Hashizume ◽  
Masahiro Yasunaga ◽  
Takumi Kawabata ◽  
...  

The 70-kDa heat shock protein (Hsp70) is up-regulated in a wide variety of tumor cell types and contributes to the resistance of these cells to the induction of cell death by anticancer drugs. Hsp70 binding protein 1 (HspBP1) modulates the activity of Hsp70 but its biological significance has remained unclear. We have now examined whether HspBP1 might interfere with the prosurvival function of Hsp70, which is mediated, at least in part, by inhibition of the death-associated permeabilization of lysosomal membranes. HspBP1 was found to be expressed at a higher level than Hsp70 in all normal and tumor cell types examined. Tumor cells with a high HspBP1/Hsp70 molar ratio were more susceptible to anticancer drugs than were those with a low ratio. Ectopic expression of HspBP1 enhanced this effect of anticancer drugs in a manner that was both dependent on the ability of HspBP1 to bind to Hsp70 and sensitive to the induction of Hsp70 by mild heat shock. Furthermore, anticancer drugs up-regulated HspBP1 expression, whereas prevention of such up-regulation by RNA interference reduced the susceptibility of tumor cells to anticancer drugs. Overexpression of HspBP1 promoted the permeabilization of lysosomal membranes, the release of cathepsins from lysosomes into the cytosol, and the activation of caspase-3 induced by anticancer drugs. These results suggest that HspBP1, by antagonizing the prosurvival activity of Hsp70, sensitizes tumor cells to cathepsin-mediated cell death.


Lab on a Chip ◽  
2018 ◽  
Vol 18 (9) ◽  
pp. 1320-1329 ◽  
Author(s):  
Chi-Ju Kim ◽  
Juhee Park ◽  
Vijaya Sunkara ◽  
Tae-Hyeong Kim ◽  
Yongjin Lee ◽  
...  

Fully integrated lab-on-a-disc for cfDNA isolation allows real-time monitoring of tumor mutation status during targeted therapy.


2017 ◽  
Vol 8 (15) ◽  
pp. 2370-2380 ◽  
Author(s):  
Manling Tang ◽  
Minglu Zhou ◽  
Yuan Huang ◽  
Jiaju Zhong ◽  
Zhou Zhou ◽  
...  

The nanoplatform of biosafe crosslinked copolymer-NPs efficiently delivers anticancer drugs to tumor cellsviablood circulation.


2017 ◽  
Vol 492 (3) ◽  
pp. 507-512 ◽  
Author(s):  
Nathan A. Koonce ◽  
Mazen A. Juratli ◽  
Chengzhong Cai ◽  
Mustafa Sarimollaoglu ◽  
Yulian A. Menyaev ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document